2019
DOI: 10.15252/embj.2018100526
|View full text |Cite
|
Sign up to set email alerts
|

Mutant Lef1 controls Gata6 in sebaceous gland development and cancer

Abstract: Mutations in Lef1 occur in human and mouse sebaceous gland (SG) tumors, but their contribution to carcinogenesis remains unclear. Since Gata6 controls lineage identity in SG, we investigated the link between these two transcription factors. Here, we show that Gata6 is a β‐catenin‐independent transcriptional target of mutant Lef1. During epidermal development, Gata6 is expressed in a subset of Sox9‐positive Lef1‐negative hair follicle progenitors that give rise to the upper SG. Overexpression of Gata6 by in ute… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
24
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(25 citation statements)
references
References 81 publications
(142 reference statements)
1
24
0
Order By: Relevance
“…In addition, according to a recent study on cutaneous T‐cell lymphoma (CTCL), GATA6 directly up‐regulates CD137L expression and promotes tumor growth . In a study of animal models of sebaceous gland (SG) tumors, Gata6 was found to control sebaceous gland development and cancer . Because GATA6 can be differentially expressed in prostate cancer, GATA6 can be used not only as a candidate biomarker for prostate cancer, but also as a potential therapeutic target .…”
Section: Gata6 and Human Cancersmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, according to a recent study on cutaneous T‐cell lymphoma (CTCL), GATA6 directly up‐regulates CD137L expression and promotes tumor growth . In a study of animal models of sebaceous gland (SG) tumors, Gata6 was found to control sebaceous gland development and cancer . Because GATA6 can be differentially expressed in prostate cancer, GATA6 can be used not only as a candidate biomarker for prostate cancer, but also as a potential therapeutic target .…”
Section: Gata6 and Human Cancersmentioning
confidence: 99%
“…101 In a study of animal models of sebaceous gland (SG) tumors, Gata6 was found to control sebaceous gland development and cancer. 102 Because GATA6 can be differentially expressed in prostate cancer, GATA6 can be used not only as a candidate biomarker for prostate cancer, but also as a potential therapeutic target. 103 The transcription factor GATA6 is also associated with the occurrence of adrenocortical tumors.…”
Section: Gata6 and Other Cancersmentioning
confidence: 99%
“…Multiple models have been proposed for SG maintenance, including models where specialised cells located either within or outside the gland are the source of replenishment [5][6][7][8][9] . Moreover, developmental studies suggest that SGs are derived from more than 1 Lrig1 expressing cells [10][11][12] . Yet, a general consensus is still lacking for how the SG forms, how it is subsequently maintained and how oncogene activation affects cell behaviour.…”
mentioning
confidence: 99%
“…A subset of Lrig1 + cells also expresses the transcription factor Gata6 which regulates sebaceous lineage specification. Gata6 + cells appear in the HF infundibulum, junctional zone, upper SG and its duct portion [ 21 , 22 ]. Other SC populations, expressing LGR6, MTS24/PLET1 and K15 and occupying the isthmus, junctional zone and bulge, can participate in the generation of SG progeny [ 23 , 24 , 25 ].…”
Section: Epidermal Stem Cells As Units Of Developmentmentioning
confidence: 99%
“…Lrig1 and Lrg6 expression appears in the basal layer that is responsible for SG homeostasis. Gata6 lo cells coexpress Lrig1 and Lrg6; postnatally, these cells are localized in the junctional zone, the upper part of SGs and sebaceous duct [ 21 , 22 ]. SGSCs are not dependent on Lgr6 + SCs from adjacent compartments comprising HFs and IFE.…”
Section: Epidermal Scs As Units Of Tissue Maintenancementioning
confidence: 99%